In last trading session, NeuroSense Therapeutics Ltd (NASDAQ:NRSN) saw 0.43 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $1.18 trading at $0.06 or 5.36% at ring of the bell on the day assigns it a market valuation of $27.41M. That closing price of NRSN’s stock is at a discount of -90.68% from its 52-week high price of $2.25 and is indicating a premium of 56.78% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.18 million shares which gives us an average trading volume of 243.29K if we extend that period to 3-months.

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information

Upright in the green during last session for gaining 5.36%, in the last five days NRSN remained trading in the green while hitting it’s week-highest on Friday, 03/14/25 when the stock touched $1.18 price level, adding 2.68% to its value on the day. NeuroSense Therapeutics Ltd’s shares saw a change of -1.67% in year-to-date performance and have moved 4.42% in past 5-day. NeuroSense Therapeutics Ltd (NASDAQ:NRSN) showed a performance of 1.98% in past 30-days. Number of shares sold short was 0.23 million shares which calculate 1.74 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.06% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 27.71% while estimates for its earnings growth in next 5 years are of 19.07%.

NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s Major holders

Insiders are in possession of 31.23% of company’s total shares while institution are holding 2.78 percent of that, with stock having share float percentage of 4.05%. Investors also watch the number of corporate investors in a company very closely, which is 2.78% institutions for NeuroSense Therapeutics Ltd that are currently holding shares of the company. ARMISTICE CAPITAL, LLC is the top institutional holder at NRSN for having 1.58 million shares of worth $1.77 million. And as of 2024-06-30, it was holding 10.2822 of the company’s outstanding shares.

The second largest institutional holder is MEITAV INVESTMENT HOUSE LTD, which was holding about 40000.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.2597 of outstanding shares, having a total worth of $44800.0.